News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GlaxoSmithKline (GSK)'s New Smelly Drug Is An Utter Stinkbomb


4/1/2014 8:40:02 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Usually, saying that an experimental medicine stinks is a metaphorical statement. You know, its efficacy is marginal, or there are serious side effects. Not so for GlaxoSmithKline's GSK -0.39% darapladib, results of which were presented at the annual meeting of the American College of Cardiology and published in the New England Journal of Medicine yesterday.

Hey, check out all the research scientist jobs. Post your resume today!

Read at Forbes


comments powered by Disqus
Forbes
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES